1. Vega F, Chang CC, Schwartz MR, et al. 2006; Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease. Am J Surg Pathol. 30:539–544. DOI:
10.1097/00000478-200604000-00017. PMID:
16625103.
Article
2. Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES. 2011; NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood. 117:1447–1452. DOI:
10.1182/blood-2010-08-302737. PMID:
20966166. PMCID:
PMC3056587.
Article
3. Takeuchi K, Yokoyama M, Ishizawa S, et al. 2010; Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood. 116:5631–5637. DOI:
10.1182/blood-2010-06-290650. PMID:
20829373.
Article
5. Montes-Moreno S, King RL, Oschlies I, et al. 2020; Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas. Virchows Arch. 476:667–681. DOI:
10.1007/s00428-019-02704-8. PMID:
31773249.
Article
7. Hwang SH, Park JS, Jeong SH, Yim H, Han JH. 2016; Indolent NK cell proliferative lesion mimicking NK/T cell lymphoma in the gallbladder. Human Pathology: Case Reports. 5:39–42. DOI:
10.1016/j.ehpc.2016.01.004.
Article
9. Ishibashi Y, Matsuzono E, Yokoyama F, et al. 2013; A case of lymphomatoid gastropathy: a self-limited pseudomalignant natural killer (NK)-cell proliferative disease mimicking NK/T-cell lymphomas. Clin J Gastroenterol. 6:287–290. DOI:
10.1007/s12328-013-0397-7. PMID:
26181731.
Article
10. Xia D, Morgan EA, Berger D, Pinkus GS, Ferry JA, Zukerberg LR. 2019; NK-cell enteropathy and similar indolent lymphoproliferative disorders: a case series with literature review. Am J Clin Pathol. 151:75–85. DOI:
10.1093/ajcp/aqy108. PMID:
30212873.